Physician profile
Benjamin T Bevill
NPI 1235491408
$31,279.04
in general payments reported to CMS, 2019-2025
49 companies · $14K in 2025
The $14K reported for 2025 was more than what 94% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,867 · 2020: $317 · 2021: $622 · 2022: $6,668 · 2023: $5,741 · 2024: $2,105 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $12K · Food and Beverage: $5,822 · Travel and Lodging: $2,462 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,020.00 |
| Food and Beverage | $5,822.32 |
| Travel and Lodging | $2,462.13 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $19,351.79 | 2022-2025 | Da Vinci Surgical System |
| Inari Medical, INC. | $2,165.39 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Steris Corporation | $1,420.67 | 2023 | |
| Olympus Corporation of The Americas | $1,284.48 | 2019 | |
| Pulmonx Corporation | $1,269.37 | 2022-2024 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Glaxosmithkline, LLC. | $793.39 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Abiomed | $499.98 | 2021-2024 | Impella |
| Insmed, INC. | $454.54 | 2019-2025 | Arikayce |
| Boehringer Ingelheim Pharmaceuticals, INC. | $422.01 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Astrazeneca Pharmaceuticals LP | $400.55 | 2019-2025 | Tagrisso, Fasenra, Tezspire |
| United Therapeutics Corporation | $348.68 | 2020-2025 | Tyvaso, Tyvaso, Remodulin |
| Grifols USA, LLC | $345.16 | 2019-2025 | Prolastin-C Liquid |
| Merck Sharp & Dohme LLC | $252.85 | 2019-2025 | Zerbaxa, Recarbrio |
| Abbott Laboratories | $239.69 | 2023-2025 | 2nd Gen Centrimag Primary Console |
| Regeneron Healthcare Solutions, INC. | $219.23 | 2022-2025 | Libtayo, Dupixent |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galvanize Therapeutics, INC | $185.69 | 2023-2024 | Aliya System |
| Actelion Pharmaceuticals US, INC. | $158.24 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Mylan Specialty L.P. | $156.91 | 2019-2024 | Yupelri |
| Genentech USA, INC. | $155.05 | 2019-2025 | Tecentriq |
| Boston Scientific Corporation | $138.27 | 2019-2024 | Spaceoar Vue System - 10ml |
| Genzyme Corporation | $126.39 | 2022-2025 | |
| Getinge USA Sales, LLC | $125.58 | 2019 | |
| Baxter Healthcare | $93.04 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Mallinckrodt Hospital Products INC. | $63.80 | 2023-2024 | Acthar |
| Ambu INC. | $47.83 | 2022-2023 | |
| Alexion Pharmaceuticals, INC. | $44.48 | 2021-2023 | Ultomiris |
| Viatris Specialty LLC | $40.74 | 2025 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $39.24 | 2021-2024 | Ninlaro |
| Vapotherm INC | $37.68 | 2022 | |
| Ani Pharmaceuticals, INC. | $36.69 | 2024 | Purified Cortrophin Gel |
| Pfizer INC. | $30.61 | 2020-2023 | |
| Abbvie INC. | $30.11 | 2024 | |
| Vifor Pharma, INC. | $25.26 | 2024 | Zemaira |
| Tempus Ai, INC | $23.29 | 2025 | Xt Cdx |
| Amgen INC. | $23.20 | 2024 | Tezspire |
| Inogen, INC. | $21.54 | 2022 | |
| Verona Pharma, INC. | $20.98 | 2025 | Ohtuvayre |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Electromed, INC. | $19.90 | 2023 | Smartvest |
| Circassia INC. | $19.86 | 2019 | |
| Olympus America INC. | $19.03 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $17.43 | 2025 | Vibativ |
| Philips North America LLC | $16.74 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.49 | 2022 | |
| Emd Serono, INC. | $14.35 | 2024 | |
| Lilly USA, LLC | $14.14 | 2025 | Verzenio, Jaypirca, Retevmo |
| Ethicon INC. | $13.99 | 2020 | |
| Allergan, INC. | $11.24 | 2020 | |
| Endogastric Solutions, INC | $5.47 | 2023 | Esophyx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Bevill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.